CATest

CAT for Healthcare Professionals

click here to print this page

What are the CAT Questions?

There are eight items in the CAT.

Patients read the two statements for each item, which describe the best and worst scenario, and decide where on the scale (0-5) they fit. This system was chosen because it is reliable and simple to use. Scores for each of the 8 items are summed to give single, final score (minimum 0, maximum 40) – this is a measure of the overall impact of a patient’s condition on their life1,2.

Scores for the individual items within the questionnaire will provide insight into the relative influence that the different components of COPD have on its overall impact on a patient’s life – thus, they will highlight problematic areas, which can be explored further during consultation and ultimately addressed through intervention1,2.

The COPD Assessment Test items:





Reference

  1. Jones et al. European Respiratory Journal 2009; 34: 648-654.
  2. The COPD Assessment Test healthcare professional user guide: expert guidance on frequently asked questions. Jones PW, Jenkins C, Bauerle O (on behalf of the CAT Development Steering Group).

Page Last Updated: April 25, 2012

COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies.
©2009 GlaxoSmithKilne group of companies. All rights reserved.

Click Here to take the CATest
 
To print a paper version of CAT, click here. You will need Adobe Acrobat to read this file. Click here to download Adobe Acrobat.
 
If you are a healthcare professional, this guide will show you how to use the CAT in the best way.
GlaxoSmithKline

COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies.
©2009 GlaxoSmithKilne group of companies. All rights reserved.
Contact us
This website is intended for residents of the UK only.
Please read the legal notices and privacy notices.
Specific medical advice should always be sought from a qualified medical practitioner.
The development of the COPD Assessment Test was funded by GlaxoSmithKline.
GlaxoSmithKline UK Limited. Registered in England. Company No. 4310159.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.
Code number: UK/RESP/0014/12 April 2012.